This could be partially explained by the fact that initially, MSH6 carriers were thought to have a higher endometrial carcinoma risk and were thus more actively counselled to have a prophylactic hysterectomy in The Netherlands. This evidence concerns the gene MSH6 and endometrial carcinoma.